BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23160422)

  • 1. Where, when, and in what form does sporadic Alzheimer's disease begin?
    Braak H; Del Tredici K
    Curr Opin Neurol; 2012 Dec; 25(6):708-14. PubMed ID: 23160422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An experimental model of Braak's pretangle proposal for the origin of Alzheimer's disease: the role of locus coeruleus in early symptom development.
    Ghosh A; Torraville SE; Mukherjee B; Walling SG; Martin GM; Harley CW; Yuan Q
    Alzheimers Res Ther; 2019 Jul; 11(1):59. PubMed ID: 31266535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's pathogenesis: is there neuron-to-neuron propagation?
    Braak H; Del Tredici K
    Acta Neuropathol; 2011 May; 121(5):589-95. PubMed ID: 21516512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathological process underlying Alzheimer's disease in individuals under thirty.
    Braak H; Del Tredici K
    Acta Neuropathol; 2011 Feb; 121(2):171-81. PubMed ID: 21170538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolutional aspects of Alzheimer's disease pathogenesis.
    Braak H; Del Tredici K
    J Alzheimers Dis; 2013; 33 Suppl 1():S155-61. PubMed ID: 22699850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down but Not Out: The Consequences of Pretangle Tau in the Locus Coeruleus.
    Chalermpalanupap T; Weinshenker D; Rorabaugh JM
    Neural Plast; 2017; 2017():7829507. PubMed ID: 29038736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice.
    Ishihara T; Zhang B; Higuchi M; Yoshiyama Y; Trojanowski JQ; Lee VM
    Am J Pathol; 2001 Feb; 158(2):555-62. PubMed ID: 11159192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid.
    Braak H; Zetterberg H; Del Tredici K; Blennow K
    Acta Neuropathol; 2013 Nov; 126(5):631-41. PubMed ID: 23756600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurons associated with aggrecan-based perineuronal nets are protected against tau pathology in subcortical regions in Alzheimer's disease.
    Morawski M; Brückner G; Jäger C; Seeger G; Arendt T
    Neuroscience; 2010 Sep; 169(3):1347-63. PubMed ID: 20497908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The preclinical phase of the pathological process underlying sporadic Alzheimer's disease.
    Braak H; Del Tredici K
    Brain; 2015 Oct; 138(Pt 10):2814-33. PubMed ID: 26283673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoform transition from four-repeat to three-repeat tau underlies dendrosomatic and regional progression of neurofibrillary pathology.
    Hara M; Hirokawa K; Kamei S; Uchihara T
    Acta Neuropathol; 2013 Apr; 125(4):565-79. PubMed ID: 23407988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.
    Braak H; Thal DR; Ghebremedhin E; Del Tredici K
    J Neuropathol Exp Neurol; 2011 Nov; 70(11):960-9. PubMed ID: 22002422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different Populations of Human Locus Ceruleus Neurons Contain Heavy Metals or Hyperphosphorylated Tau: Implications for Amyloid-β and Tau Pathology in Alzheimer's Disease.
    Pamphlett R; Kum Jew S
    J Alzheimers Dis; 2015; 45(2):437-47. PubMed ID: 25547633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of tau pathology in the locus coeruleus (LC) in age-associated pathophysiology and Alzheimer's disease pathogenesis: Potential strategies to protect the LC against aging.
    Satoh A; Iijima KM
    Brain Res; 2019 Jan; 1702():17-28. PubMed ID: 29274876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of tau in the development of Alzheimer's disease].
    Takashima A
    Brain Nerve; 2010 Jul; 62(7):701-8. PubMed ID: 20675874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alzheimer's disease: lesions and their progression].
    Duyckaerts C; Colle MA; Delatour B; Hauw JJ
    Rev Neurol (Paris); 1999; 155 Suppl 4():S17-27. PubMed ID: 10637934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin expression in globose tangles in the locus coeruleus in brains of patients with Alzheimer's and Parkinson's diseases.
    Kida E; Barcikowska M
    Neurosci Lett; 1992 Feb; 136(1):59-62. PubMed ID: 1321968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease.
    Grudzien A; Shaw P; Weintraub S; Bigio E; Mash DC; Mesulam MM
    Neurobiol Aging; 2007 Mar; 28(3):327-35. PubMed ID: 16574280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
    Pei JJ; Sjögren M; Winblad B
    Curr Opin Psychiatry; 2008 Nov; 21(6):555-61. PubMed ID: 18852562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC's afferent and efferent connections.
    Iba M; McBride JD; Guo JL; Zhang B; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2015 Sep; 130(3):349-62. PubMed ID: 26150341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.